rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1996-10-25
|
pubmed:abstractText |
The influence of immunoactive medicines on the cell immunity have been studied. There were differences in reaction to T-activin and Thymalin between various patients with septic postoperative complications. Thymalin stimulated T-cells while acting with immunoglobulins or immune plasmas only. T-activin led to the increase in the number of T-lymphocytes and B-lymphocytes independently of it's cooperation with the vaccines. The stimulating effect of myelopid demonstrated itself by increase in the number of B-lymphocytes and immunoglobulins M and G after 14 days of treatment. The positive clinical effect was more impressive when immunomodulators were used in combinations with the vaccines; still it did not correlate completely with the dynamics of the cell immunity parameters.
|
pubmed:language |
rus
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Activins,
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides,
http://linkedlifedata.com/resource/pubmed/chemical/T-activin,
http://linkedlifedata.com/resource/pubmed/chemical/Thymus Extracts,
http://linkedlifedata.com/resource/pubmed/chemical/Thymus Hormones,
http://linkedlifedata.com/resource/pubmed/chemical/activin B,
http://linkedlifedata.com/resource/pubmed/chemical/myelopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/thymalin
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0023-1207
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
104-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8754918-Activins,
pubmed-meshheading:8754918-Adjuvants, Immunologic,
pubmed-meshheading:8754918-Bone Marrow,
pubmed-meshheading:8754918-Empyema, Pleural,
pubmed-meshheading:8754918-Humans,
pubmed-meshheading:8754918-Immunoglobulins,
pubmed-meshheading:8754918-Lymphocyte Subsets,
pubmed-meshheading:8754918-Oligopeptides,
pubmed-meshheading:8754918-Osteomyelitis,
pubmed-meshheading:8754918-Peptides,
pubmed-meshheading:8754918-Peritonitis,
pubmed-meshheading:8754918-Phagocytosis,
pubmed-meshheading:8754918-Postoperative Complications,
pubmed-meshheading:8754918-Suppuration,
pubmed-meshheading:8754918-Surgical Wound Infection,
pubmed-meshheading:8754918-Thymus Extracts,
pubmed-meshheading:8754918-Thymus Hormones,
pubmed-meshheading:8754918-Time Factors
|
pubmed:year |
1996
|
pubmed:articleTitle |
[Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications].
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|